Summary
- Current Price
- As of today, CAPR price is $32.11, up +6.61% on
- Current Price All-Time High
- CAPR price is currently -99.08% below its historical high of $3,500.00 set on
- Market Cap
- CAPR current market cap is $2B, up +292.62% over the past 365 days
- PE Ratio
- CAPR PE ratio is unknown
- Revenue
- CAPR current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for CAPR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Capricor Therapeutics, Inc. |
| Ticker | NASDAQ: CAPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | capricor.com |
| Employees | 160 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $32.11 | |
| Price, 1D Change | +6.61% | |
| $2B | ||
| - | ||
| - | ||
| 1.61 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$2.26 | ||
| EPS, 1Y Change | -96.70% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | NLTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.26 | ||
| EPS Estimate | N/A | $0.08 |
| EPS Est. Change | N/A | +103.71% |
| $0.00 | ||
| Revenue Estimate | N/A | $134.84M |
| Revenue Est. Change | N/A | - |
| Current Price | $32.11 | |
| Price Target | - | $52.50 |
| Price Tgt. Change | - | +63.50% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.07 | -$1.15 | -7.58% | |
| -$2.16 | -$2.26 | -4.70% | |
| $0.08 | N/A | +103.71% | |
| -$0.38 | N/A | +83.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $20.97M | $22.27M | +6.18% | |
| $590.00K | $0.00 | -100.00% | |
| $134.84M | N/A | - | |
| $117.59M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $32.11 | |
| $15.43 | ||
| SMA 200 vs Price | -51.96% | |
| $27.23 | ||
| SMA 50 vs Price | -15.19% | |
| 1.61 | ||
| $2.17 | ||
| 59.82 | ||
| 82.91% | ||
| 389.99% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.26 | ||
| -$1.89M | ||
| - | ||
| -$108.14M | ||
| - | ||
| -$105.04M | ||
| - | ||
| -$106.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.06 | ||
| 9.01 | ||
| 9.01 | ||
| - | ||
| - | ||
| 18.13 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.71 | ||
| -13.61 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $305.79M | ||
| $318.13M | ||
| $359.95M | ||
| $322.94M | ||
| $54.15M | ||
| $35.84M | ||
| $17.94M | ||
| $3.62M | ||
| $1.65M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $105.04M | ||
| $108.14M | ||
| $1.89M | ||
| $0.00 | ||
| $1.89M | ||
| $0.00 | ||
| $1,600.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$69.81M | ||
| $97.48M | ||
| $248.89M | ||
| $11.72M | ||
| -$81.54M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| Piper Sandler | → | |
| Oppenheimer | → | |
| Maxim Group | → | |
| HC Wainwright & Co. | → | |
| Roth Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CAPR
FAQ
What is the ticker symbol for Capricor Therapeutics, Inc.?
The ticker symbol for Capricor Therapeutics, Inc. is NASDAQ:CAPR
Does Capricor Therapeutics, Inc. pay dividends?
No, Capricor Therapeutics, Inc. does not pay dividends
What sector is Capricor Therapeutics, Inc. in?
Capricor Therapeutics, Inc. is in the Healthcare sector
What industry is Capricor Therapeutics, Inc. in?
Capricor Therapeutics, Inc. is in the Biotechnology industry
What country is Capricor Therapeutics, Inc. based in?
Capricor Therapeutics, Inc. is headquartered in United States
When did Capricor Therapeutics, Inc. go public?
Capricor Therapeutics, Inc. initial public offering (IPO) was on February 13, 2007
Is Capricor Therapeutics, Inc. in the S&P 500?
No, Capricor Therapeutics, Inc. is not included in the S&P 500 index
Is Capricor Therapeutics, Inc. in the NASDAQ 100?
No, Capricor Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Capricor Therapeutics, Inc. in the Dow Jones?
No, Capricor Therapeutics, Inc. is not included in the Dow Jones index
When was Capricor Therapeutics, Inc. last earnings report?
Capricor Therapeutics, Inc.'s most recent earnings report was on March 12, 2026
When does Capricor Therapeutics, Inc. report earnings?
The next expected earnings date for Capricor Therapeutics, Inc. is May 13, 2026
Data Sources & References
- CAPR Official Website www.capricor.com
- CAPR Profile on Yahoo Finance finance.yahoo.com/quote/CAPR
- CAPR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/capr